Tag: alios-biopharma

Investment Services & Trading Picture Gallery

Alios BioPharma to Present Preclinical Data on Its Anti-HCV Nucleotides AL-335 and AL-516 at the 2014 American Association for the Study of Liver Diseases Annual Meeting

November 6, 2014
Presse

Nucleotide Analog AL-335 Demonstrated Synergistic Effects With Other Treatments for HCV, Including Johnson & Johnson--s Anti-HCV…

Continue Reading
Picture Gallery Venture Capital

Alios BioPharma Announces Acquisition Agreement With Johnson & Johnson

September 30, 2014
Presse

Agreement Provides Opportunity to Accelerate Development of Antiviral Portfolio and Expand Alios Infectious Disease Drug Discovery…

Continue Reading
Investment Services & Trading Picture Gallery

Alios BioPharma Initiates Phase 1 Clinical Trial for Respiratory Syncytial Virus (RSV) Infection

May 30, 2013
Presse

ALS-8176 Is a First-in-Class Nucleoside Analog Targeting the RSV Polymerase and Has Demonstrated Potent Antiviral Activity…

Continue Reading